First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)

By Grávalos Castro, Cristina. Critical Reviews in Oncology/Hematology, 2011 . 77(1):78-84. , Formato Vancouver: Sastre J, Aranda E, Grávalos C, Massutí B, Varella García M, Rivera F, et al. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD). Crit Rev Oncol Hematol. 2011;77(1):78-84.

Place Hold on First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)

Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives

By Castellano, Daniel | Cortés-Funes Castro, Hernán | García Escobar, Ignacio | Sepúlveda Sánchez, Juan Manuel. Critical Reviews in Oncology/Hematology, 2011 . 80(1):100-113. , Formato Vancouver: García-Escobar I, Sepúlveda J, Castellano D, Cortés-Funes H. Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives. Crit Rev Oncol Hematol. 2011;80(1):100-13.

Place Hold on Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives

Search for 'Provider:Critical Reviews in Oncology/Hematology,'

First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)

Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives